Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia: The Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia Study.

J Clin Neurol · 2021 · PMC8242309 · PMID 34184441

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

likely to be significantno p-value reported

17 Therefore, the expected clinical benefit of BP reduction observed in the present study is likely to be significant.

also in 1,824 other papers

showed a trendno p-value reported

Baseline SBP values showed a trend of achieving the target BP, but did not reach a statistical significance [for 10-mm Hg SBP increase: 0.90 (0.81–1.00), p =0.059].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.